General Information
Revision date
2010-04-03
Product name
EAZI-BREED CIDR Sheep and Goat Device
Substance name
Progesterone is a female sex hormone
CAS No.
57-83-0
1.2.1 Relevant identified uses
Intravaginal hormonal device for oestrus synchronisation (controlled breeding) in
Icons in SDS
Company Information
company name
Pfizer Australia Pty Ltd
Section 2
Hazard statements
This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. Not Hazardous - No criteria found
Precautionary statements
Not Hazardous - No criteria found
SUSDP Classification
S5
ADG classification
None allocated. Not a Dangerous Good
UN Number
None allocated EEm E m meeerrrgggeeennncccyyy OOvvveeerrrvvviiieeew O ww Physical Description & colour: T-shaped device (5.5 cm body and 5.5 cm wings) with a silicone skin containing progesterone moulded over a preformed nylon spine. Odour: No data.
Health hazards
no significant risk factors have been found for this product PPooottteeennntttiiiaaalll P HHeeeaaalllttthhh H EEffffffeeeccctttsss E Symptoms of overexposure to progesterone: Loss of libido, breakthrough bleeding, hypertension, porphyria, cholestatic liver damage and sterility. In men, may result in some of the general symptoms exhibited by women; may also inhibit spermatogenesis. Foetal exposure may result in congenital heart defects, limb reduction defects, virilisation & genital abnormalities. Inhalation Short term exposure: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. Long Term exposure: No data for health effects associated with long term inhalation. Skin Contact: Short term exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. Long Term exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short term exposure: Exposure via eyes is considered to be unlikely. This product is believed to be not irritating to eyes. Long Term exposure: No data for health effects associated with long term eye exposure. Ingestion: Short term exposure: Significant oral exposure is considered to be unlikely. This product is unlikely to cause any irritation problems in the short or long term. Long Term exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: Progesterone is classed by NTP as reasonably anticipated to be a Human carcinogen. IARC: No significant ingredient is classified as carcinogenic by IARC.